Extracellular cold-inducible RNA-binding protein (eCIRBP) is a key driver of sterile inflammation following ischemia/reperfusion (I/R) injury, such as during cardiac surgery. While eCIRBP’s interaction with the TLR4/MD2 complex is known to activate the NF-κB pathway, its role in activating the JAK/STAT3 pathway via the IL-6 receptor is less understood. To investigate this, human THP-1-derived macrophage-like cells were stimulated with a recombinant human active CIRBP peptide (rhCIRBP) with or without Stattic pre-treatment, a selective STAT3 phosphorylation (Y705) inhibitor. Activation of IκBα/NF-κB and JAK/STAT3 was assessed by Western blotting, while gene expressions of inflammatory markers were measured via RT-qPCR. LPS stimulation significantly induced all inflammatory targets investigated (IL-6, IL-1β, TNF-α, MCP-1, ICAM, and SOCS3), while rhCIRBP only significantly induced IL-1β, TNF-α, and ICAM in the THP-1 macrophages. Interestingly, Stattic inactivated both STAT3 and NF-κB pathways, thus resulting in the attenuation of all induced inflammatory responses observed. Our findings confirm eCIRBP as a potent inflammatory mediator, corresponding with reported elevated concentrations of circulatory eCIRBP in patients after cardiac surgery and those suffering from hemorrhagic shock and sepsis. Additionally, we also highlight the crosstalk between the STAT3/ NF-κB pathways that may offer a novel therapeutic strategy for managing both sterile and non-sterile inflammation.